A2AR antagonist treatment for multiple sclerosis: Current progress and future prospects

Chenxing Qi, Yijia Feng, Yiwei Jiang, Wangchao Chen, Serhii Vakal, Jiang Fan Chen, Wu Zheng*

*Corresponding author for this work

Research output: Chapter in Book/Conference proceedingChapterScientificpeer-review

Fingerprint

Dive into the research topics of 'A2AR antagonist treatment for multiple sclerosis: Current progress and future prospects'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science